These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8858671)

  • 21. Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. Members of the Ceftibuten Pharyngitis International Study Group.
    Pichichero ME; Mclinn SE; Gooch WM; Rodriguez W; Goldfarb J; Reidenberg BE
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S102-7. PubMed ID: 7567309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 6-day amoxicillin vs 10-day penicillin V for GABHS.
    Bramson R
    J Fam Pract; 1997 Mar; 44(3):241-2. PubMed ID: 9071235
    [No Abstract]   [Full Text] [Related]  

  • 23. Frequency of symptomatic relapses of group A beta-hemolytic streptococcal tonsillopharyngitis in children from 4 pediatric practices following penicillin, amoxicillin, and cephalosporin antibiotic treatment.
    Casey JR; Kahn R; Gmoser D; Atlas E; Urbani K; Luber S; Pellman H; Pichichero ME
    Clin Pediatr (Phila); 2008 Jul; 47(6):549-54. PubMed ID: 18490665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis.
    Jakob-Sölder B; Steininger C; Eigentler A; Allerberger F
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):811-2. PubMed ID: 9923529
    [No Abstract]   [Full Text] [Related]  

  • 25. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.
    Cohen R
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S129-34. PubMed ID: 14770076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of short-course therapy with the ketolide telithromycin compared with 10 days of penicillin V for the treatment of pharyngitis/tonsillitis.
    Norrby SR; Rabie WJ; Bacart P; Mueller O; Leroy B; Rangaraju M; Butticaz-Iroudayassamy E
    Scand J Infect Dis; 2001; 33(12):883-90. PubMed ID: 11868759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the efficacy, safety and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in children: results of a multicenter, open comparative study. The Swiss Tonsillopharyngitis Study Group.
    Schaad UB; Heynen G
    Pediatr Infect Dis J; 1996 Sep; 15(9):791-5. PubMed ID: 8878223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and bacteriologic efficacy of amoxycillin b.d. (45 mg/kg/day) versus amoxycillin t.d.s (40 mg/kg/day) in children with group A beta-hemolytic streptococcal tonsillopharyngitis.
    Aguilar A; Tinoco JC; Macias M; Huicho L; Levy J; Trujillo H; Lopez P; Pereira M; Maqbool S; Bhutta ZA; Sacy RA; Deacon S
    J Chemother; 2000 Oct; 12(5):396-405. PubMed ID: 11128559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis.
    Dajani AS; Kessler SL; Mendelson R; Uden DL; Todd WM
    Pediatr Infect Dis J; 1993 Apr; 12(4):275-9. PubMed ID: 8483620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variables influencing penicillin treatment outcome in streptococcal tonsillopharyngitis.
    Pichichero ME; Hoeger W; Marsocci SM; Murphy AM; Francis AB; Dragalin V
    Arch Pediatr Adolesc Med; 1999 Jun; 153(6):565-70. PubMed ID: 10357295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis.
    Lennon DR; Farrell E; Martin DR; Stewart JM
    Arch Dis Child; 2008 Jun; 93(6):474-8. PubMed ID: 18337284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loracarbef versus penicillin V in the treatment of streptococcal pharyngitis and tonsillitis.
    Müller O; Spirer Z; Wettich K
    Infection; 1992; 20(5):301-8. PubMed ID: 1428189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy for pharyngitis and tonsillitis caused by group A beta-hemolytic streptococci: a meta-analysis comparing the efficacy and safety of cefadroxil monohydrate versus oral penicillin V.
    Deeter RG; Kalman DL; Rogan MP; Chow SC
    Clin Ther; 1992; 14(5):740-54. PubMed ID: 1468091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness and tolerance of cefixime in comparison with penicillin V in bacterial pharyngitis and tonsillitis in children. Cefixime Study Group].
    Adam D; Hostalek U
    Klin Padiatr; 1994; 206(1):26-9. PubMed ID: 8152203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study.
    Skoog Ståhlgren G; Tyrstrup M; Edlund C; Giske CG; Mölstad S; Norman C; Rystedt K; Sundvall PD; Hedin K
    BMJ; 2019 Oct; 367():l5337. PubMed ID: 31585944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Streptococcal-A tonsillopharyngitis: a 5-day course of cefuroxime axetil versus a 10-day course of penicillin V. results depending on the children's age.
    Scholz H
    Chemotherapy; 2004 Apr; 50(1):51-4. PubMed ID: 15084807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of bacampicillin hydrochloride, penicillin V, and amoxicillin in the treatment of acute tonsillitis and/or pharyngitis due to beta-hemolytic streptococci.
    Pankey GA; Gleason C; File TM; Brown W
    Rev Infect Dis; 1981; 3(1):154-8. PubMed ID: 6784224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of 5-day cefdinir treatment for streptococcal pharyngitis in children. Cefdinir Pediatric Pharyngitis Study Group.
    Tack KJ; Hedrick JA; Rothstein E; Nemeth MA; Keyserling C; Pichichero ME
    Arch Pediatr Adolesc Med; 1997 Jan; 151(1):45-9. PubMed ID: 9006528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefuroxime axetil and penicillin V compared in the treatment of group A beta-hemolytic streptococcal pharyngitis.
    Gooch WM; Swenson E; Higbee MD; Cocchetto DM; Evans EC
    Clin Ther; 1987; 9(6):670-7. PubMed ID: 3125976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis.
    Norrby SR; Quinn J; Rangaraju M; Leroy B
    Clin Microbiol Infect; 2004 Jul; 10(7):615-23. PubMed ID: 15214873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.